• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Appl Environ Microbiol . Bio-Rad and QIAGEN digital PCR platforms provide equivalent quantification for wastewater-based SARS-CoV-2 surveillance

tetano

Editor, Senior Moderator
Appl Environ Microbiol


. 2026 Apr 22:e0008326.
doi: 10.1128/aem.00083-26. Online ahead of print.
Bio-Rad and QIAGEN digital PCR platforms provide equivalent quantification for wastewater-based SARS-CoV-2 surveillance

Thomas Clerkin[SUP] #[/SUP][SUP] 1 [/SUP], Steph Smith[SUP] #[/SUP][SUP] 1 [/SUP], Kevin Zhu[SUP] 2 [/SUP], Denene Blackwood[SUP] 1 [/SUP], Javier Gallard-Góngora[SUP] 1 [/SUP], Drew Capone[SUP] 3 [/SUP], Joe Brown[SUP] 2 [/SUP], Rachel T Noble[SUP] 1 2 [/SUP]


Affiliations
Abstract

Digital PCR (dPCR) is increasingly used for wastewater surveillance due to its precision, absolute quantification, and reduced sensitivity to inhibition compared to quantitative PCR (qPCR). Although the Bio-Rad QX200 and QIAGEN QIAcuity dPCR platforms are widely adopted, their performance has not been directly compared for wastewater applications. We conducted a blinded comparison of these platforms using 93 archived wastewater influent samples from North Carolina collected in 2021-2022, spanning three orders of magnitude in SARS-CoV-2 concentration (1 × 10[SUP]3[/SUP]-5 × 10[SUP]5[/SUP] copies L[SUP]-1[/SUP]). Samples were stratified into low, medium, and high concentration bins and analyzed in triplicate for N1 and N2 gene targets and a bovine coronavirus processing control. Both platforms demonstrated statistically equivalent quantification across all targets, with mean differences ≤0.12 log copies L[SUP]-1[/SUP] (R[SUP]2[/SUP] > 0.93). Coefficients of variation were similar (3.96%-7.61%), with no significant differences across concentration bins except for N2 in the low bin (difference: 0.87 percentage points). Measurement variability correlated strongly with wastewater treatment plant site (R[SUP]2[/SUP] = 0.89) rather than platform, indicating that sample matrix characteristics drive precision more than the analytical platform. Process limits of detection ranged from 2,160 to 2,680 copies L[SUP]-1[/SUP] for Bio-Rad QX200 and 5,650-9,700 copies L[SUP]-1[/SUP] for QIAGEN QIAcuity for N1 and N2, respectively. The Bio-Rad QX200 platform processed samples 32% faster (305 vs 435 minutes per 96 wells), while QIAGEN QIAcuity offered 29% lower consumables cost ($4.68 vs $6.11 per well). These findings support the interchangeable use of both platforms for wastewater surveillance, with platform selection based on laboratory-specific operational needs.IMPORTANCEAs wastewater-based epidemiology transitions from emergency response to sustained public health infrastructure, standardized molecular methods are essential for reliable data integration across surveillance networks. This study provides the first blinded comparison of two dPCR platforms widely deployed for wastewater pathogen surveillance in the United States. We demonstrate quantitative equivalence between Bio-Rad QX200 and QIAGEN QIAcuity platforms across three orders of magnitude in viral concentration, establishing that data from both platforms can be interpreted interchangeably for public health decision-making. This platform equivalence is critical as national surveillance systems aggregate data from diverse laboratories and as monitoring expands beyond SARS-CoV-2 to encompass additional respiratory viruses, antimicrobial resistance genes, and emerging pathogens. Our findings provide a methodological foundation for multi-platform surveillance networks and demonstrate that measurement variability is driven primarily by sample matrix characteristics rather than analytical platform choice.

Keywords: CDC NWSS; SARS-CoV-2; digital PCR; droplet digital PCR; method validation; platform comparison; public health surveillance; quantitative detection; wastewater surveillance; wastewater-based epidemiology.

 
Back
Top Bottom